UW study focuses on Alzheimer’s disease treatment and prevention in Black adults
As the first of a new generation of Alzheimer’s disease drugs hit the market, some researchers are troubled by the lack of clinical data available on the effectiveness of these drugs in Black people.
Innovative clinical trial targets recurrent BK infection in kidney transplant recipients
Kidney transplant patients like Tessa Adolph, from Rockford, Illinois, face an age-old problem to protect their new kidney and bodies after transplant surgery: how to prevent infections while also safeguarding their new kidney from damage or rejection.
Recognizing Clinical Trials Day: How major advances in medicine happen
When stakes are high, clinical trials rise to the challenge to keep moving medicine forward.
UW Study: Most teens actually have healthy relationship with digital technology
Parents play a major role in whether teens’ use of digital technology is healthy or puts their mental and physical health at risk, according to a new study from the University of Wisconsin School of Medicine and Public Health.
Study finds reducing maternal blood pressure leads to better birth outcomes
A large study of more than 2,400 pregnant women found that treating mildly elevated blood pressure reduces preterm births and preeclampsia, a high blood pressure condition that threatens the lives of mothers and babies.
New study seeks to expand eye screenings for rural diabetic patients throughout the United States
More patients in rural areas across the nation could have increased access to vision-saving eye screenings through a new clinical trial led by researchers at the University of Wisconsin School of Medicine and Public Health.
Study examines text messages as method for successful weight loss
Enrollment to open for an interactive study aims to help people build habits for a healthier lifestyle, lose weight and keep it off.
Moderna COVID-19 vaccine pediatric clinical trial to focus on ages 6 months to 5 years
The KidCOVE phase three clinical trial at the University of Wisconsin School of Medicine and Public Health, which is evaluating the safety and effectiveness of the Moderna COVID-19 vaccine in children, has shifted focus to kids 6 months to 5 years old.
UW Health treats first patient in U.S. with investigational cell therapy for heart disease
Appleton resident Donald Krause became the first patient in the country last week to undergo an investigational cell therapy for a debilitating heart condition called chronic myocardial ischemia (CMI).
UW study examines allergic reactions to COVID-19 vaccines
Researchers from the UW School of Medicine and Public Health are seeking participants for a clinical study that examines whether the mRNA COVID-19 vaccines (Pfizer/BioNTech and Moderna) pose an increased risk for allergic reactions in individuals who are already considered “highly allergic.”
Nasia Safdar named inaugural associate dean for clinical trials
Nasia Safdar, MD, PhD, has been named the University of Wisconsin School of Medicine and Public Health’s inaugural associate dean for clinical trials and the research director of the new Wisconsin Medicine Institute for Clinical Trials, a joint venture between the school and UW Health.
UW selected as site for Moderna COVID-19 vaccine pediatric clinical trial
Aug. 16, 2021 update: Thanks to overwhelming interest from our community, UW Health and the UW School of Medicine and Public Health have already met the recruitment objectives for Moderna’s pediatric COVID-19 vaccine clinical trial. If your child is selected to be part of the trial, you will be contacted directly. Advancements in science, public health, and clinical care often cannot happen without a supportive and engaged citizenry, and we greatly appreciate this community’s ongoing efforts to help end this pandemic.